ImmunocorePlc-adr Share Price Today
(NASDAQ: IMCR)

Name: ImmunocorePlc-adr Share Price Today (NASDAQ: IMCR) - ImmunocorePlc-adr Stock Price Live Quote | INDmoney
Brand: INDmoney
Rating: 4.7 (371551 reviews)

ImmunocorePlc-adr share price is $29.8 & ₹2,590.37 as on 8 Mar 2025, 2.30 'hrs' IST

$29.8

▲

-1.01

(-3.28%)

Market is closed - opens 8 PM, 10 Mar 2025

View live ImmunocorePlc-adr share price in Dollar and Rupees. Guide to invest in ImmunocorePlc-adr stock from India, including Indian investor sentiment. Get details on Indian mutual funds investing in ImmunocorePlc-adr, along with analyst recommendations, forecasts, and comprehensive financials.

ImmunocorePlc-adr share price movements

Today's Low: $29.50
Today's High: $31.04
$29.80
1.01%
Downside
Day's Volatility :4.96%
Upside
3.99%
52 Weeks Low: $27.69
52 Weeks High: $66.00
$29.80
7.08%
Downside
52 Weeks Volatility :58.05%
Upside
54.85%

ImmunocorePlc-adr (IMCR) Returns

Period	Immunocore Holdings Plc-adr	Sector (Health Care)	Index (Russel 2000)
3 Months	-6.44%	3.2%	0.0%
6 Months	-12.02%	-3.7%	0.0%
1 Year	-51.12%	1.9%	0.0%
3 Years	14.62%	14.9%	-12.3%

ImmunocorePlc-adr (IMCR) Key Statistics

in dollars & INR

Previous Close	$30.81
Open	$31.04
Today's High	$31.04
Today's Low	$29.5
Market Capitalization	$1.5B
Today's Volume	$173.1K
52 Week High	$66.0
52 Week Low	$27.69
Revenue TTM	$310.2M
EBITDA	$-48.2M
Earnings Per Share (EPS)	$-1.02
Profit Margin	-16.47%
Quarterly Earnings Growth YOY	8.22%
Return On Equity TTM	-14.01%

How to invest in ImmunocorePlc-adr Stock (IMCR) from India?

It is very easy for Indian residents to invest directly in ImmunocorePlc-adr from India. Indian investors can open a free US stocks account on the INDmoney app. You can find live prices of the ImmunocorePlc-adr stock in both Indian Rupees (INR) and US Dollars (USD). Search for ImmunocorePlc-adr or IMCR on the INDmoney app and click on Buy or SIP. You can invest by choosing quantities of shares of ImmunocorePlc-adr or rupee/ dollar value or set up a fixed SIP amount to be invested every month or week.

For example: You can easily buy Rs.100 worth of ImmunocorePlc-adr shares which would translate to 0.029 fractional shares of ImmunocorePlc-adr as of today. Learn more about fractional investing.

Indians can now also easily transfer and add money to their US stocks account via the INDmoney app. Invest in US Stocks from India, including recognised companies like ImmunocorePlc-adr, in just a few clicks!

Returns in ImmunocorePlc-adr (IMCR) for Indian investors in Rupees

The ImmunocorePlc-adr stock calculator helps Indian investors calculate returns based on the historical performance of the stock. Just choose your investment amount and duration to get insights and invest more confidently. See stock returns as well as the effect of dollar appreciation over different durations.

Investment Value

₹1,00,000

ImmunocorePlc-adr investment value today

Current value as on today

₹53,979

Returns

₹46,021

(-46.02%)

Returns from ImmunocorePlc-adr Stock

₹51,115 (-51.12%)

Dollar Returns

₹5,095 (+5.09%)

Indian investors sentiment towards ImmunocorePlc-adr (IMCR)

-62%

Period: Feb 6, 2025 to Mar 8, 2025. Change in 30 Days versus previous period

Search interest for ImmunocorePlc-adr Stock from India on INDmoney has decreased by -62% in the last 30 days, reflecting a downward trend in search activity.

Global Institutional Holdings in ImmunocorePlc-adr

T. Rowe Price Investment Management,Inc.
13.38%
Wellington Management Company LLP
13.22%
RTW INVESTMENTS, LLC
9.73%
FMR Inc
9.62%
PRIMECAP Management Company
5.33%
T. Rowe Price Associates, Inc.
4.37%

Analyst Recommendation on ImmunocorePlc-adr

Buy

91%Buy

8%Hold

0%Sell

Based on 24 Wall street analysts offering stock ratings for ImmunocorePlc-adr(by analysts ranked 0 to 5 stars)

Based on 24 analyst

Current
1M Ago
3M Ago

Buy

Hold

Sell

Analyst Forecast on ImmunocorePlc-adr Stock (IMCR)

What analysts predicted

Upside of 117.95%

Target:

$64.95

Current:

$29.80

Insights on ImmunocorePlc-adr Stock (Ticker Symbol: IMCR)

Price Movement
In the last 1 year, IMCR stock has moved down by -51.6%
Increasing Revenue
Revenue is up for the last 4 quarters, 70.50M → 84.05M (in $), with an average increase of 5.7% per quarter
Decreasing Net Profit
Netprofit is down for the last 2 quarters, 8.73M → -23.77M (in $), with an average decrease of 372.1% per quarter
IMCR vs ALNY (1 yr)
In the last 1 year, Alnylam Pharmaceuticals, Inc. has given 63.2% return, outperforming this stock by 114.8%
IMCR vs VRTX (3 yr)
In the last 3 years, Vertex Pharmaceuticals Incorporated has given 50.7% return, outperforming this stock by 34.7%
Price to Sales
ForIMCR every $1 of sales, investors are willing to pay $4.8, whereas for Alnylam Pharmaceuticals, Inc., the investors are paying $13.9 for every $1 of sales.

IMCR ImmunocorePlc-adr Financials in INR & Dollars

	FY19	Y/Y Change
Revenue	$33.6M	↑ 8.52%
Net Income	$-136.1M	↑ 45.09%
Net Profit Margin	-404.89%	↓ 102.07%

	FY20	Y/Y Change
Revenue	$40.5M	↑ 17.32%
Net Income	$-99.5M	↓ 28.71%
Net Profit Margin	-246.04%	↑ 158.85%

	FY21	Y/Y Change
Revenue	$35.3M	↓ 11.93%
Net Income	$-175.0M	↑ 77.51%
Net Profit Margin	-495.94%	↓ 249.9%

	FY22	Y/Y Change
Revenue	$175.0M	↑ 441.99%
Net Income	$-50.2M	↓ 68.66%
Net Profit Margin	-28.68%	↑ 467.26%

	FY23	Y/Y Change
Revenue	$315.8M	↑ 73.53%
Net Income	$-70.0M	↑ 34.11%
Net Profit Margin	-22.17%	↑ 6.51%

	FY24	Y/Y Change
Revenue	$310.2M	↑ 24.37%
Net Income	$-51.1M	↓ 7.6%
Net Profit Margin	-16.47%	↑ 5.7%

	Q3 FY23	Q/Q Change
Revenue	$77.7M	↑ 31.11%
Net Income	$2.9M	↓ 116.45%
Net Profit Margin	3.7%	↑ 33.17%

	Q4 FY23	Q/Q Change
Revenue	$133.7M	↑ 68.68%
Net Income	$-33.4M	↓ 1240.71%
Net Profit Margin	-25.01%	↓ 28.71%

	Q1 FY24	Q/Q Change
Revenue	$89.6M	↓ 33.26%
Net Income	$-31.1M	↓ 7.5%
Net Profit Margin	-34.66%	↓ 9.65%

	Q2 FY24	Q/Q Change
Revenue	$75.4M	↑ 6.95%
Net Income	$-11.6M	↓ 52.46%
Net Profit Margin	-15.41%	↑ 19.25%

	Q3 FY24	Q/Q Change
Revenue	$80.2M	↑ 6.43%
Net Income	$8.7M	↓ 175.21%
Net Profit Margin	10.89%	↑ 26.3%

	Q4 FY24	Q/Q Change
Revenue	$84.1M	↑ 4.74%
Net Income	$-23.8M	↓ 372.1%
Net Profit Margin	-28.28%	↓ 39.17%

	FY19	Y/Y Change
Profit	$-97.3M	↓ 414.2%

	FY20	Y/Y Change
Profit	$-60.0M	↓ 39.86%

	FY21	Y/Y Change
Profit	$-62.1M	↑ 4.5%

	FY22	Y/Y Change
Profit	$174.4M	↓ 406.78%

	FY23	Y/Y Change
Profit	$314.5M	↑ 73.36%

	FY24	Y/Y Change
Profit	$307.5M	↑ 23.79%

	Q3 FY23	Q/Q Change
Profit	$77.4M	↑ 33.02%

	Q4 FY23	Q/Q Change
Profit	$134.0M	↑ 69.8%

	Q1 FY24	Q/Q Change
Profit	$89.3M	↓ 33.65%

	Q2 FY24	Q/Q Change
Profit	$73.7M	↑ 4.89%

	Q3 FY24	Q/Q Change
Profit	$79.8M	↑ 8.29%

	Q4 FY24	Q/Q Change
Profit	$83.7M	↑ 4.91%

	FY19	Y/Y Change
Operating Cash Flow	$-132.7M	↑ 509.74%
Investing Cash Flow	$-5.4M	↓ 107.13%
Financing Cash Flow	$72.2M	↑ 54481.19%

	FY20	Y/Y Change
Operating Cash Flow	$-81.4M	↓ 40.25%
Investing Cash Flow	$627.3K	↓ 111.29%
Financing Cash Flow	$155.7M	↑ 110.32%

	FY21	Y/Y Change
Operating Cash Flow	$-172.6M	↑ 114.2%
Investing Cash Flow	$-488.3K	↓ 178.59%
Financing Cash Flow	$367.5M	↑ 138.27%

	FY22	Y/Y Change
Operating Cash Flow	$-38.1M	↓ 75.9%
Investing Cash Flow	$234.9K	↓ 152.59%
Financing Cash Flow	$168.3M	↓ 49.96%

	Q3 FY23	Q/Q Change
Operating Cash Flow	$7.7M	↓ 360.35%
Investing Cash Flow	$2.7M	↓ 20.88%
Financing Cash Flow	$9.7M	↑ 6.11%

ImmunocorePlc-adr Technicals Summary

Sell

Neutral

Buy

ImmunocorePlc-adr is currently not in a favorable trading position ( SELL ) according to technical analysis indicators.

ImmunocorePlc-adr (IMCR) Vs Peers

Company Name	1 Month	6 Month	1 Year	3 Years	5 Years
Immunocore Holdings Plc-adr	-0.83%	-12.02%	-51.12%	14.62%	-24.8%
Regeneron Pharmaceuticals, Inc.	-0.35%	-38.2%	-26.64%	12.24%	48.94%
Beone Medicines Ltd	10.55%	27.81%	50.17%	34.28%	58.1%
Vertex Pharmaceuticals Incorporated	4.04%	3.65%	17.81%	101.83%	111.83%
Alnylam Pharmaceuticals, Inc.	-11.47%	-3.41%	64.0%	52.29%	123.53%

Company Name	P/E Ratio	P/B Ratio	PEG Ratio	EPS	ROE	ROA	Div Yield	BVPS
Immunocore Holdings Plc-adr	NA	NA	NA	-1.22	-0.14	-0.04	NA	7.21
Regeneron Pharmaceuticals, Inc.	18.22	18.22	1.03	42.83	0.16	0.07	0.01	273.57
Beone Medicines Ltd	NA	NA	NA	1.43	-0.19	-0.06	NA	31.22
Vertex Pharmaceuticals Incorporated	32.84	NA	1.34	18.06	-0.03	0.13	NA	63.87
Alnylam Pharmaceuticals, Inc.	NA	NA	-0.49	0.57	-15.01	-0.03	NA	0.52

Company Name	Analyst View	Market Cap	5 Years Return %	PE Ratio	Profit Margin
Immunocore Holdings Plc-adr	Buy	$1.5B	-24.8%	NA	-16.47%
Regeneron Pharmaceuticals, Inc.	Buy	$76.4B	48.94%	18.22	31.07%
Beone Medicines Ltd	NA	$28.9B	58.1%	NA	-16.92%
Vertex Pharmaceuticals Incorporated	Buy	$124.7B	111.83%	32.84	-4.86%
Alnylam Pharmaceuticals, Inc.	Buy	$32.1B	123.53%	NA	-12.37%

About ImmunocorePlc-adr

Immunocore Holdings plc, a commercial-stage biotechnology company, engages in the development of immunotherapies for the treatment of cancer, infectious, and autoimmune diseases. The company offers KIMMTRAK for the treatment of patients with unresectable or metastatic uveal melanoma. It also develops other programs for oncology, including tebentafusp that is in Phase 2/3 clinical trial to treat advanced cutaneous melanoma. In addition, the company's product pipeline comprises IMC-F106C, which is in a Phase 3 clinical trial to treat first line advanced cutaneous melanoma; and in a Phase 1/2 clinical trial in multiple tumor types, such as platinum resistant ovarian, non-small cell lung, and endometrial carcinoma. Further, it develops IMC-R117C, which is in phase 1 clinical trial to treat colorectal and gastrointestinal cancers; IMC-M113V, which is in phase 1 clinical trial to treat human immunosuppression virus; IMC-I109V, which is in a Phase I clinical trial in patients with chronic hepatitis B virus; IMC-T119C, which is in preclinical trial for multiple solid tumor cancers; IMC-P115C, which is in preclinical trial to treat multiple solid tumor cancers; and IMC-S118AI to treat type 1 diabetes and is in preclinical trial. Immunocore Holdings plc was founded in 1999 and is headquartered in Abingdon, the United Kingdom.

Organization	ImmunocorePlc-adr
Employees	493
CEO	Dr. Bahija Jallal Ph.D.
Industry	Services

Management People of ImmunocorePlc-adr

Name	Title
Dr. Bahija Jallal Ph.D.	CEO & Executive Director
Mr. Travis A. Coy	CFO, Executive VP & Head of Corporate Development
Ms. Tina St. Leger	Executive VP & Chief Human Resources Officer
Dr. David Berman M.D., Ph.D.	Executive Vice President of Research & Development
Mr. John Trainer M.B.A.	SVP & Chief Operating Officer
Mr. John Goll III	SVP, Finance & Chief Accounting Officer
Ms. Annelise Vuidepot Ph.D.	Senior VP, CTO and Research & UK Site Lead
Mr. Sean D. Buckley	VP & Chief Information Officer
Clayton Robertson	Head of Investor Relations
Ms. Lily Margaret Hepworth	Senior VP, General Counsel & Company Secretary

Important FAQs about investing in IMCR Stock from India :

What is ImmunocorePlc-adr share price today?

ImmunocorePlc-adr share price today stands at $29.80, Open: $31.04 ; Previous Close: $30.81 ; High: $31.04 ; Low: $29.50 ; 52 Week High: $66.00 ; 52 Week Low: $27.69.

The stock opens at $31.04, after a previous close of $30.81. The stock reached a daily high of $31.04 and a low of $29.50, with a 52-week high of $66.00 and a 52-week low of $27.69.

Can Indians buy ImmunocorePlc-adr shares?

Yes, Indians can invest in the ImmunocorePlc-adr (IMCR) from India.

With INDmoney, you can buy ImmunocorePlc-adr at 0 brokerage. The step-by-step process is as follows:

Open your zero cost US Stocks account and zero balance IND linked savings a/c (this can be done in less than 3 minutes)
Transfer funds to your US Stocks account using your IND linked savings a/c (It takes 24 hours excluding Saturday and Sunday). With INDmoney, you get the best INR USD exchange rates.
Once funds are transferred successfully, you can buy ImmunocorePlc-adr at zero transaction cost.

How can I buy ImmunocorePlc-adr shares from India?

It is very easy to buy ImmunocorePlc-adr from India. With INDmoney, you can open a US stocks account in less than 3 minutes. Transfer funds in 24 hours and buy stocks very easily - that too at 0 brokerage. All this is done at 0 account opening & management fee, 0 brokerages, and at the same time you get the best rupee-US dollar exchange rate.

Can Fractional shares of ImmunocorePlc-adr (IMCR) be purchased?

Yes, you can buy fractional shares of ImmunocorePlc-adr with INDmoney app.

What are the documents required to start investing in ImmunocorePlc-adr stocks?

To start investing in ImmunocorePlc-adr, You will need the following documents:

Proof of Identification (PAN, Aadhaar etc)
Proof of address (Aadhaar, Voter ID etc)

These documents are required as per RBI's guidelines to create your IND linked savings a/c so that you can execute for global fund transfer. The entire process is paperless and can be completed seamlessly.